I started practice in cath lab before digital age! We had to develop cine films and watch on a Tagarno, i am nearly in tears!

Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trial | ⁦EuroIntervention⁩ eurointervention.pcronline.com/article/immedi…

#cardiology #cardiovascular #cardiotwitter #cardioX

Two is plenty: Total arterial anaortic OPCAB x 3 using LIMA & left radial with LIMA-LAD, left RA-OM1 & top end on LIMA, left RA-distal RCA & top end on OM1 radial graft. There is always plenty of conduit if you are a specialist coronary surgeon.
#CoronarySurgeryAsSubspecialty

Fascinating

Intracoronary electrocardiogram detects coronary microvascular dysfunction and ischemia in patients with no obstructive coronary arteries disease
pubmed.ncbi.nlm.nih.gov/38278503/
#Cardiology

Suggestions on the second coronary artery arising from the LCC? 🧐

Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with! by Arturo Giordano et al onlinelibrary.wiley.com/doi/abs/10.100… CCIjournal

Wifi flow. Gerardo Soca trademark.

Can we trust the findings of the PREVENT trial, just published in The Lancet? To be very frank, I am not sure... Is it remotely credible a trial in which PCI with DES perfomed in high-risk lesions yields a cumulative 2-year rate of cardiac death, MI, TVR, or hospitalisation for…

Final poll results: with 677 responses, after PREVENT, 35% are ready to treat non-flow-limiting asymptomatic vulnerable plaques with preventive PCI to improve prognosis. 65% are not yet believers. 4 other trials are ongoing and more are being designed.

Coronary 4Front Giuseppe Biondi-Zoccai Less-Is-More Cardiologist WEBodenMD John Mandrola, MD David J. Cohen, MD, MSc MIЯVΛƬ #IC Gregg W. Stone MD Ash Paul Dr Roxana Mehran Victor Dayan Faisal Bakaeen MD Joe Sabik Marc Ruel, MD, MPH Gianluca Torregrossa Salvatore Brugaletta Niels R. Holm “In medio stat virtù “. Aristotle. There’s a place for CABG in #MVD . #OMT is rarely prescribed and goals are obtained only in a minority of patients

PCI and CABG volumes never recovered to pre pandemic levels. TAVR is pandemic-proof

Curious about immediate vs. staged complete revascularization in ACS patients🤔? Join Hala Kakar & MIЯVΛƬ #IC for a Live chat next Tuesday on the #BIOVASC trial's substudy findings (paper out on April 15th)!
📅Tune in at 6:00 PM on your fave social media channel! #EIJonAir

Vulnerability score vs SYNTAX score. The future has arrived.

PCI:CABG in Great Britain.

The National audit report NICOR UK in PCI published today: nicor.org.uk/interactive-re…

Thank you to my team in helping to delivering this particularly Pete Jones. Whilst intracoronary imaging rates continue to increase, Prasugrel use in ACS PCI remains poor, and delays of…

In a randomized trial including 3505 patients with an acute coronary syndrome, intravascular ultrasound-guided implantation of drug-eluting stents resulted in a lower 1-year rate of cardiac death, target vessel myocardial infarction, or clinically driven revascularisation…

Noninferiority margins exceed superiority effect estimates for mortality in cardiovascular trials in high-impact journals pubmed.ncbi.nlm.nih.gov/37421996/ via Gordon H. Guyatt et al Mamas A. Mamas Benoy Shah MD Sanjay Kaul John Mandrola, MD SABOURETCardiologist

Real-world evaluation of an algorithmic #MachineLearning guided testing approach in stable chest pain: a multinational, multicohort study bit.ly/3Jhzaj0

#EHJDigital #CDSS Nico Bruining EiC EHJ Digital Health rafavidalperez Gerhard Hindricks Ruben Casado Arroyo